Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Earth Science Tech ( (ETST) ) is now available.
On January 6, 2026, Earth Science Tech, Inc. announced that it has formally directed financial data providers, news aggregators and brokerage platforms to update its industry classification to SIC 2834, reflecting its transition since 2022 from legacy CBD and cannabis operations to a fully healthcare- and pharmaceutical-focused company. The move follows the regulatory clearance of its 15c-211 filing and is intended to eliminate outdated database tags, align its market identity with its SEC-registered status and highlight its core operational pillars of pharmaceutical compounding via RxCompoundStore.com and Mister Meds and telemedicine delivery through Peaks Curative and DOConsultations, a clarification that could influence how investors, analysts and platforms assess and present ETST within the broader healthcare and pharmaceutical space.
The most recent analyst rating on (ETST) stock is a Hold with a $0.14 price target. To see the full list of analyst forecasts on Earth Science Tech stock, see the ETST Stock Forecast page.
Spark’s Take on ETST Stock
According to Spark, TipRanks’ AI Analyst, ETST is a Neutral.
The score is supported mainly by strong recent financial performance (rapid revenue scaling, high gross margins, profitability, positive cash flow, and very low leverage). The key offset is weak technicals (below major moving averages with negative MACD and low RSI), suggesting unfavorable near-term price momentum. Valuation is moderate (P/E ~13.7), while corporate events are positive but incremental.
To see Spark’s full report on ETST stock, click here.
More about Earth Science Tech
Earth Science Tech, Inc. is a Florida-based strategic holding company operating primarily in the healthcare and pharmaceutical sectors, with a focus on compounding pharmaceuticals, telemedicine and real estate development. Through subsidiaries including RxCompoundStore.com, Mister Meds, Peaks Curative, DOConsultations, Las Villas Health Care, Avenvi, MagneChef and the Earth Science Foundation, the company manages a portfolio spanning licensed compounding pharmacies with multi-state reach, telemedicine platforms, a Spanish-language brick‑and‑mortar clinic, diversified real estate ventures, consumer products and a nonprofit that helps patients cover prescription costs.
Average Trading Volume: 68,342
Technical Sentiment Signal: Sell
Current Market Cap: $39.3M
Learn more about ETST stock on TipRanks’ Stock Analysis page.